These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4559524)

  • 41. Imipramine response in deluded depressive patients.
    Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Jul; 135(7):806-11. PubMed ID: 352160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.
    Raskin A; Crook TH
    Arch Gen Psychiatry; 1975 May; 32(5):643-9. PubMed ID: 1092283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal potentiation of imipramine and ECT in primary depression.
    Feighner JP; King LJ; Schuckit MA; Croughan J; Briscoe W
    Am J Psychiatry; 1972 Apr; 128(10):1230-8. PubMed ID: 4552204
    [No Abstract]   [Full Text] [Related]  

  • 44. Decrease in speech pause times with treatment of endogenous depression.
    Greden JF; Carroll BJ
    Biol Psychiatry; 1980 Aug; 15(4):575-87. PubMed ID: 7397288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine.
    Coppen A; Whybrow PC; Noguera R; Maggs R; Prange AJ
    Arch Gen Psychiatry; 1972 Mar; 26(3):234-41. PubMed ID: 4551048
    [No Abstract]   [Full Text] [Related]  

  • 46. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 47. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 48. Enhancement of imipramine antidepressant activity by thyroid hormone.
    Prange AJ; Wilson IC; Rabon AM; Lipton MA
    Am J Psychiatry; 1969 Oct; 126(4):457-69. PubMed ID: 4185164
    [No Abstract]   [Full Text] [Related]  

  • 49. Potentiation of a monoamine oxidase inhibitor by tryptophan.
    Glassman AH; Platman SR
    J Psychiatr Res; 1969 Dec; 7(2):83-8. PubMed ID: 4917709
    [No Abstract]   [Full Text] [Related]  

  • 50. Open trial evaluation of keto-imipramine.
    Kline NS; Winick L
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):57-62. PubMed ID: 4992567
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current problems of the clinical aspects and treatment of depressive states].
    Shternberg EIa
    Klin Med (Mosk); 1969 Sep; 47(9):20-5. PubMed ID: 4920679
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of buspirone in two separate studies.
    Goldberg HL; Finnerty R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):87-91. PubMed ID: 6759499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of ECT in affective and schizophrenic illness.
    Greenblatt M
    Am J Psychiatry; 1977 Sep; 134(9):1001-5. PubMed ID: 331967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical evaluation of a possible catechol-O-methyl transferase inhibitor in endogenous depression.
    Angrist B; Park S; Urcuyo L; Roffman M; Gershon S
    Curr Ther Res Clin Exp; 1973 Mar; 15(3):127-32. PubMed ID: 4196229
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression].
    Tétreault L; Doucet P; Blanchet A; Bordeleau JM
    Union Med Can; 1966 May; 95(5):546-53. PubMed ID: 5326793
    [No Abstract]   [Full Text] [Related]  

  • 56. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 57. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The treatment of endogenous depression with monochlorimipramin].
    Arnold OH; Heves HP
    Wien Klin Wochenschr; 1967 Jan; 79(1):3-6. PubMed ID: 5340280
    [No Abstract]   [Full Text] [Related]  

  • 59. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
    Raskin A; Schulterbrandt JG; Reatig N; McKeon JJ
    Arch Gen Psychiatry; 1970 Aug; 23(2):164-73. PubMed ID: 4913665
    [No Abstract]   [Full Text] [Related]  

  • 60. Prediction of psychopharmacologic effect in man: development and validation of a computerized diagnostic decision tree.
    Honigfeld G; Klein DF; Feldman S
    Comput Biomed Res; 1969 Jun; 2(4):350-61. PubMed ID: 4891890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.